OPTIMIZATION OF PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS IN ONCOUROLOGY: THE ROLE OF A CLINICAL PHARMACOLOGIST AND ASSESSMENT OF CLINICAL AND ECONOMIC OUTCOMES

Integrating a clinical pharmacologist into an antimicrobial stewardship program for oncourology patients significantly improved adherence to antibiotic prophylaxis guidelines, reduced antibiotic consumption and costs by over 70%, and decreased the prevalence of resistant organisms without increasing infectious complications or mortality.

The Gist

Imagine a busy hospital operating room as a high-stakes kitchen. The surgeons are the master chefs preparing complex dishes (surgeries) for patients. To keep the food safe, they need to use a specific type of "cleaning spray" (antibiotics) before they start cooking to prevent germs from spoiling the meal.

However, in this specific hospital kitchen, the chefs were using the spray all wrong. Sometimes they used too much, sometimes the wrong kind, and sometimes they kept spraying long after the cooking was done. This was wasteful, expensive, and actually making the germs stronger and harder to kill later on.

The Problem: A Recipe for Chaos
Before the study, the hospital had no strict rules on how to use this "cleaning spray." The chefs were guessing, leading to a situation where 0% of the surgeries followed the correct safety guidelines. It was like trying to bake a cake without a recipe—everyone was just winging it.

The Solution: The "Smart Sous-Chef"
Enter the Clinical Pharmacologist. Think of this person not as a doctor, but as a highly specialized "Smart Sous-Chef" or a Quality Control Expert who knows exactly how cleaning sprays work.

The hospital decided to bring this expert into the kitchen to lead a new strategy called Antimicrobial Stewardship (AMS). This wasn't just about handing out a rulebook; it was a team effort involving four key moves:

1. The Gatekeeper: The expert had to approve the spray before it was used (pre-authorization).
2. The Coach: After surgeries, they reviewed what happened and gave the chefs feedback (audit with feedback).
3. The Teacher: They taught the chefs the correct recipes (education).
4. The Handshake: They worked side-by-side with the surgeons to build trust and teamwork (handshake stewardship).

The Results: A Cleaner, Cheaper, Safer Kitchen
After introducing this "Smart Sous-Chef" and the new rules, the kitchen transformed:

• Following the Rules: Before, no one followed the recipe. After, nearly half of the prostate surgeries and over half of the kidney surgeries were done exactly right.
• Less Waste: The surgeons stopped spraying for a week straight. They now only sprayed for 2 days instead of 7. It's like switching from leaving the faucet running for a week to only turning it on when you need to wash your hands.
• Saving Money: Because they used so much less spray, the hospital saved a fortune. The cost of antibiotics dropped by 4.3 times. It's the difference between buying a luxury car and a reliable bicycle for a short trip.
• Stronger Germs, Weakened: The "super-germs" (called ESKAPE organisms) that were becoming a problem dropped significantly. By using less spray, the germs didn't get a chance to build up their armor.
• Patient Safety: The most important part? No one got hurt. The number of infections didn't go up, and no one died. The "Smart Sous-Chef" made sure that using less spray didn't mean less safety.

The Bottom Line
This study proves that when you bring a specialized expert (the Clinical Pharmacologist) into the team to guide the surgeons, everyone wins. The hospital saves money, the environment gets less chemical pollution, the germs stay weaker, and most importantly, the patients stay safe. It's a blueprint for how any hospital can stop wasting resources and start treating patients smarter.

Technical Summary

Technical Summary: Optimization of Perioperative Antibiotic Prophylaxis in Oncourology

1. Problem Statement

Perioperative antibiotic prophylaxis (PAP) in oncourology often suffers from irrational prescribing practices, leading to excessive antibiotic consumption, increased financial burdens, and the acceleration of antimicrobial resistance (AMR), particularly among multidrug-resistant organisms. There is a critical need to optimize prescribing behaviors to align with clinical guidelines while maintaining patient safety and controlling costs. This study addresses the gap in effective implementation strategies for Antimicrobial Stewardship (AMS) specifically within the high-risk context of oncourological surgeries.

2. Methodology

• Study Design: A single-center, retrospective, observational study.
• Setting: Regional Clinical Hospital No. 2 in Krasnodar, Russia.
• Population: 226 patients undergoing major oncourological surgeries (prostatectomy or nephrectomy) between 2023 and 2025.
• Intervention: Implementation of a comprehensive AMS strategy bundle centered on the active integration of a clinical pharmacologist into the surgical workflow. The bundle included:
  • Pre-authorization of antibiotics.
  • Audit and feedback mechanisms.
  • Educational initiatives for surgeons.
  • "Handshake" stewardship (direct, real-time consultation).
• Comparison: Two distinct periods were analyzed:
  • Pre-intervention: 125 patients.
  • Post-intervention: 101 patients.
• Endpoints:
  • Primary: Adherence to PAP protocols.
  • Secondary: Incidence of infectious complications, antibiotic consumption (Defined Daily Doses per 100 bed-days), direct drug costs, microbial landscape shifts, and the Drug Resistance Index (DRI).

3. Key Contributions

The study introduces a model where a clinical pharmacologist acts as a central driver for AMS in a surgical setting, rather than a passive observer. It demonstrates that a multi-faceted intervention (combining administrative control, education, and real-time feedback) can effectively alter surgeon behavior in a specialized field like oncourology. Furthermore, it provides empirical evidence linking stewardship interventions directly to both clinical safety and significant economic savings.

4. Key Results

The implementation of the AMS bundle yielded statistically significant improvements across clinical, microbiological, and economic metrics:

• Protocol Adherence:
  • Pre-intervention adherence was 0%.
  • Post-intervention adherence rose to 47.7% for prostatectomies and 55.6% for nephrectomies.
• Antibiotic Utilization:
  • Duration of Therapy: Reduced dramatically from a mean of 7 days to 2 days ($p < 0.001$).
  • Consumption: Decreased by 31.2% (measured in DDD/100 bed-days).
• Economic Impact:
  • Direct costs for antibacterial drugs were reduced by a factor of 4.3.
• Microbiological Outcomes:
  • The prevalence of ESKAPE organisms (a group of highly resistant pathogens) in the microbial profile decreased from 26.3% to 16.4%.
• Patient Safety:
  • Infectious Complications: No statistically significant increase was observed (2.4% pre- vs. 3.0% post-; $p = 1.000$).
  • Mortality: Remained at 0% in both groups.

5. Significance and Conclusion

This study validates that integrating a clinical pharmacologist into the oncourology workflow is a highly effective strategy for optimizing PAP. The results indicate that such interventions can:

1. Drastically reduce irrational antibiotic use and shorten treatment duration without compromising patient safety (no increase in infections or mortality).
2. Mitigate antimicrobial resistance by lowering the selection pressure of broad-spectrum antibiotics, evidenced by the decline in ESKAPE organisms.
3. Generate substantial cost savings, making the approach economically viable for healthcare systems.

The authors conclude that this pharmacist-led AMS model serves as a scalable template for other surgical departments aiming to balance guideline adherence, infection control, and economic efficiency.